A CD8αβ co-receptor modified to contain an intracellular CD28 signaling tail enhances TCR-engineered T cell function independent of solid-tumor-associated co-stimulatory ligands

Journal:

Nature Communications

Published:

2026-01-03

DOI:

10.1038/s41467-025-67446-5

Affiliations:

16

Authors:

29

Go to article

Institutions	Authors	Share
Fred Hutchinson Cancer Center, United States of America (USA)	24.666667 24.666667 24.666667	0.85
UW Medicine, United States of America (USA)	2.666667	0.09
Seattle Children's Research Institute, United States of America (USA)	1.000000	0.03
University of Washington (UW), United States of America (USA)	0.333333	0.01
UW-Fred Hutchinson Molecular and Cellular Biology PhD Program (UW-Fred Hutch MCB ), United States of America (USA)	0.333333	0.01

Interested in Oncology and Carcinogenesis?